Assignee
ORICELL THERAPEUTICS CO LTD
CN·4 granted patents·9 pending applications·0 citations·filing 2018–2024
Top patents by PatentIndex Score
13 records- 0174US12479921B2Anti-PD-L1 antibody and use thereofORICELL THERAPEUTICS CO LTD·Filed 2024·Granted Nov 25, 2025·0 cites·12 claims
- 0263US2024400989A1Method for promoting proliferation of immune cellsORICELL THERAPEUTICS CO LTD·Filed 2024·Application pending·0 cites
- 0359US2025057950A1Chimeric antigen receptor targeting gprc5d and application thereofORICELL THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0457US2024384001A1Anti-gprc5d antigen binding protein and use thereofORICELL THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0556US2025213691A1Antigen binding protein targeting msln and use thereofORICELL THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0652US2025177527A1Chimeric antigen receptor targeting cldn18.2 and msln and use thereofORICELL THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0749US11993655B2Anti-PD-L1 antibody and use thereofORICELL THERAPEUTICS CO LTD·Filed 2018·Granted May 28, 2024·0 cites·18 claims
- 0849US2024182562A1Cldn18.2 antigen-binding protein and use thereofORICELL THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 0949US2024383992A1Bcma-targeting chimeric antigen receptor and use thereofORICELL THERAPEUTICS CO LTD·Filed 2022·Application pending·0 cites
- 1048US2024366672A1Chimeric antigen receptor and use thereofORICELL THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 1146US12054556B2Anti-PD-L1 antibody and use thereofORICELL THERAPEUTICS CO LTD·Filed 2021·Granted Aug 6, 2024·0 cites·13 claims
- 1241US2022389076A1Modified immune cell and use thereofORICELL THERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
- 1340US12005080B2Method for promoting proliferation of immune cellsORICELL THERAPEUTICS CO LTD·Filed 2019·Granted Jun 11, 2024·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when ORICELL THERAPEUTICS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →